Scientists build tiny immune labs to crack pediatric cancer code

NCT ID NCT05890781

Recruiting now Knowledge-focused Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

Summary

This study aims to create tiny, lab-grown models called 'immune organoids' from the cells of children and young adults with cancer. Researchers will use these models to study how the immune system interacts with tumors like brain cancer, kidney cancer, neuroblastoma, and sarcoma. The goal is to gain new knowledge about these diseases to help develop better future treatments, not to directly treat participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Gustave Roussy
RECRUITING

Villejuif, 94805, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hopital Necker
RECRUITING

Paris, Île-de-France Region, 75015, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BRAIN TUMOR KIDNEY TUMOR NEUROBLASTOMA SARCOMA